TrialBMC cancer2017

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).

Mikkel Bandak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.